General Dynamics Corporation vs Mesoblast Limited — how do they compare? General Dynamics Corporation trades at $391.11 (market cap $106.03B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: General Dynamics Corporation is far larger — about 48× Mesoblast Limited's market cap, and General Dynamics Corporation pays a 1.62% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| GD | MESO | |
|---|---|---|
Market Cap | $106.03B | $2.21B |
Sector | Industrials | Technology |
52-Week High | $395.97 | $20.96 |
52-Week Low | $312.53 | $12.88 |
Enterprise Value | $111.17B | $2.21B |
Dividend Yield | 1.62% | — |
Trailing returns across standard periods
Latest headlines on both assets
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →